| PEG + Placebo Group A (n = 221) | PEG + LB Group B (n = 221) |
---|---|---|
Constipation | 16.6Â %(37) | 15Â %(33) |
Chronic lower abdominal pain | 31Â %(69) | 34Â %(75) |
Diarrhea | 8.8Â %(19) | 10Â %(22) |
Blood in motions | 21Â %(46) | 17.5Â %(39) |
Unexplained weight loss | 1.9Â %(4) | 1Â %(2) |
Anemia under evaluation | 2.7Â %(6) | 2.5Â %(6) |
IBD follow up | 14Â %(31) | 16Â %(36) |
Family H/O CRC or polyposis | 1.2Â %(3) | 0.8Â %(2) |
Evaluation of abnormality by other imaging | 2Â %(4) | 1.8Â %(4) |
Others | 0.8Â % (2) | 1Â %(2) |